Literature DB >> 20404856

Requirement for cyclin D3 in germinal center formation and function.

Jonathan U Peled1, J Jessica Yu, Jeganathan Venkatesh, Enguang Bi, B Belinda Ding, Melissa Krupski-Downs, Rita Shaknovich, Piotr Sicinski, Betty Diamond, Matthew D Scharff, B Hilda Ye.   

Abstract

Germinal centers (GC) of secondary lymphoid tissues are critical to mounting a high-affinity humoral immune response. B cells within the GC undergo rapid clonal expansion and selection while diversifying their antibody genes. Although it is generally believed that GC B cells employ a unique proliferative program to accommodate these processes, little is known about how the GC-associated cell cycle is orchestrated. The D-type cyclins constitute an important component of the cell cycle engine that enables the cells to respond to physiological changes. Cell type- and developmental stage-specific roles of D-type cyclins have been described but the cyclin D requirement during GC reaction has not been addressed. In this study, we report that cyclin D3 is largely dispensable for proliferation and Ig class switching of in vitro activated B cells. In contrast, GC development in Ccnd3(-/-) mice is markedly impaired, as is the T cell-dependent antibody response. Within the GC, although both switched and unswitched B cells are affected by cyclin D3 inactivation, the IgM(-) pool is more severely reduced. Interestingly, despite a compensatory increase in cyclin D2 expression, a significant number of Ccnd3(-/-) GC B cells accumulate in quiescent G0 state. Lastly, although cyclin D3 inactivation did not disrupt BCL6 expression in GC B cells, it completely blocked the GC promoting effect of BCL6 overexpression, suggesting that cyclin D3 acts downstream of BCL6 to regulate GC formation. This is the first demonstration that cyclin D3 plays an important and unique role at the GC stage of B cell development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404856      PMCID: PMC2997820          DOI: 10.1038/cr.2010.55

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  49 in total

Review 1.  Signatures of the immune response.

Authors:  A L Shaffer; A Rosenwald; E M Hurt; J M Giltnane; L T Lam; O K Pickeral; L M Staudt
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

2.  The physiologic role of CD19 cytoplasmic tyrosines.

Authors:  Yue Wang; Stephen R Brooks; Xiaoli Li; Amy N Anzelon; Robert C Rickert; Robert H Carter
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

3.  BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

Authors:  A L Shaffer; X Yu; Y He; J Boldrick; E P Chan; L M Staudt
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

4.  Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling.

Authors:  Ralf Küppers; Ulf Klein; Ines Schwering; Verena Distler; Andreas Bräuninger; Giorgio Cattoretti; Yuhai Tu; Gustavo A Stolovitzky; Andrea Califano; Martin-Leo Hansmann; Riccardo Dalla-Favera
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

5.  Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.

Authors:  Martin Filipits; Ulrich Jaeger; Gudrun Pohl; Thomas Stranzl; Ingrid Simonitsch; Alexandra Kaider; Cathrin Skrabs; Robert Pirker
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

6.  A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.

Authors:  Justin Lamb; Sridhar Ramaswamy; Heide L Ford; Bernardo Contreras; Robert V Martinez; Frances S Kittrell; Cynthia A Zahnow; Nick Patterson; Todd R Golub; Mark E Ewen
Journal:  Cell       Date:  2003-08-08       Impact factor: 41.582

7.  B cell receptor signal strength determines B cell fate.

Authors:  Stefano Casola; Kevin L Otipoby; Marat Alimzhanov; Sibille Humme; Nathalie Uyttersprot; Jeffery L Kutok; Michael C Carroll; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

8.  Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice.

Authors:  Philip D Bardwell; Caroline J Woo; Kaichun Wei; Ziqiang Li; Alberto Martin; Stephen Z Sack; Tchaiko Parris; Winfried Edelmann; Matthew D Scharff
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

9.  Requirement for cyclin D3 in lymphocyte development and T cell leukemias.

Authors:  Ewa Sicinska; Iannis Aifantis; Laurent Le Cam; Wojciech Swat; Christine Borowski; Qunyan Yu; Adolfo A Ferrando; Steven D Levin; Yan Geng; Harald von Boehmer; Piotr Sicinski
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

10.  CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells.

Authors:  Michelle R Tourigny; Josie Ursini-Siegel; Hayyoung Lee; Kai-Michael Toellner; Adam F Cunningham; David S Franklin; Scott Ely; Meihong Chen; Xiao-Feng Qin; Yue Xiong; Ian C M MacLennan; Selina Chen-Kiang
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

View more
  37 in total

Review 1.  Germinal centres and B cell lymphomagenesis.

Authors:  Katia Basso; Riccardo Dalla-Favera
Journal:  Nat Rev Immunol       Date:  2015-03       Impact factor: 53.106

2.  Substituting threonine 187 with alanine in p27Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age.

Authors:  Hongling Zhao; Frederick Bauzon; Enguang Bi; J Jessica Yu; Hao Fu; Zhonglei Lu; Jinhua Cui; Hyungjun Jeon; Xingxing Zang; B Hilda Ye; Liang Zhu
Journal:  J Biol Chem       Date:  2015-01-12       Impact factor: 5.157

3.  Lymphocyte lineage-specific and developmental stage specific mechanisms suppress cyclin D3 expression in response to DNA double strand breaks.

Authors:  Amy DeMicco; Tyler Reich; Rahul Arya; Adrian Rivera-Reyes; Megan R Fisher; Craig H Bassing
Journal:  Cell Cycle       Date:  2016-06-21       Impact factor: 4.534

4.  Burkitt lymphoma-related TCF3 mutations alter TCF3 alternative splicing by disrupting hnRNPH1 binding.

Authors:  Takashi Yamazaki; Lizhi Liu; Erin G Conlon; James L Manley
Journal:  RNA Biol       Date:  2020-06-04       Impact factor: 4.652

5.  TLR7, a third signal for the robust generation of spontaneous germinal center B cells in systemic lupus erythematosus.

Authors:  Hongye Fan; Deshan Ren; Yayi Hou
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

6.  Flip the switch: BTG2-PRMT1 protein complexes antagonize pre-B-cell proliferation to promote B-cell development.

Authors:  Glendon S Wu; Craig H Bassing
Journal:  Cell Mol Immunol       Date:  2018-02-12       Impact factor: 11.530

7.  Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.

Authors:  Deshan Ren; Fei Liu; Guanjun Dong; Ming You; Jianjian Ji; Yahong Huang; Yayi Hou; Hongye Fan
Journal:  Cell Mol Immunol       Date:  2015-07-06       Impact factor: 11.530

Review 8.  New insights into pre-BCR and BCR signalling with relevance to B cell malignancies.

Authors:  Robert C Rickert
Journal:  Nat Rev Immunol       Date:  2013-08       Impact factor: 53.106

9.  Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.

Authors:  Sandrine Sander; Dinis P Calado; Lakshmi Srinivasan; Karl Köchert; Baochun Zhang; Maciej Rosolowski; Scott J Rodig; Karlheinz Holzmann; Stephan Stilgenbauer; Reiner Siebert; Lars Bullinger; Klaus Rajewsky
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

10.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.